Cormedix Stock (NASDAQ: CRMD) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 653.31K |
Day Range | - - - |
52 Wk Range | 2.57 - 7.00 |
Market Cap | $225.88M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 18.14% |
Days to Cover | 22.67 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cormedix (NASDAQ:CRMD) through any online brokerage.
Other companies in Cormedix’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), Xeris Biopharma Holdings (NASDAQ:XERS) and Terns Pharma (NASDAQ:TERN).
There is no analysis for Cormedix.
Cormedix has a consensus price target of $13.60.
The stock price for Cormedix (NASDAQ: CRMD) is $4.11 last updated July 2, 2024 at 5:22 PM EDT.
There are no upcoming dividends for Cormedix.
Cormedix’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Cormedix.
Cormedix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.